Trends in Modifiable Risk Factors Amongst First Presentation ST Elevation Myocardial Infarction Patients in a Large Longitudinal Registry

Inflammation: the next target for secondary prevention in coronary artery disease

“…Secondary prevention including antiplatelet, antihypertensive and lipid lowering medicines, as well as behavioural and lifestyle interventions are established treatments, and their implementation continues to be a global health system challenge 1 . Yet even if well implemented, residual elevated risk remains for recurrent events, the nature of which may be changing in line with the changes seen to risk factor profiles of patients with CAD 2 . Observational studies have shown that people with high inflammatory states and autoimmune conditions have a high prevalence of cardiovascular disease (CVD) and higher risk of repeat cardiovascular events, including mortality 3,4 .…”